AMGN Amgen Inc

$298.50

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/2/2025

About Amgen Inc

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.

Website: https://www.amgen.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
318154
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, US
Valuation
Market Cap
$149.09B
P/E Ratio
36.63
PEG Ratio
0.94
Price to Book
25.35
Performance
EPS
$7.57
Dividend Yield
3.43%
Profit Margin
12.20%
ROE
67.50%
Technicals
50D MA
$303.90
200D MA
$305.62
52W High
$338.98
52W Low
$251.27
Fundamentals
Shares Outstanding
537M
Target Price
$317.12
Beta
0.58

AMGN EPS Estimates vs Actual

● Estimated
● Actual

AMGN News & Sentiment

Oct 02, 2025 • Motley Fool SOMEWHAT-BULLISH
2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer
These stocks have been raising their payouts much faster than most dividend payers.
Oct 01, 2025 • Zacks Commentary BULLISH
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Sep 30, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Sep 26, 2025 • Benzinga SOMEWHAT-BULLISH
Amgen Expands US Manufacturing Network Amid New Tariff Policy - Amgen ( NASDAQ:AMGN )
Just when the Trump administration announced a 100% tariff on pharmaceuticals starting in October, Amgen Inc ( NASDAQ: AMGN ) announced a $650 million expansion of its U.S. manufacturing network.
Sep 26, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Amgen Inc. ( AMGN ) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Sep 24, 2025 • Zacks Commentary NEUTRAL
Amgen ( AMGN ) Dips More Than Broader Market: What You Should Know
Amgen (AMGN) closed at $279.22 in the latest trading session, marking a -2.65% move from the prior day.
Sentiment Snapshot

Average Sentiment Score:

0.185
50 articles with scored sentiment

Overall Sentiment:

Bullish

AMGN Reported Earnings

May 01, 2025
Mar 31, 2025 (Post market)
0.64 Surprise
  • Reported EPS: $4.90
  • Estimate: $4.26
  • Whisper: —
  • Surprise %: 15.0%
Feb 04, 2025
Dec 31, 2024 (Post market)
0.23 Surprise
  • Reported EPS: $5.31
  • Estimate: $5.08
  • Whisper: —
  • Surprise %: 4.5%
Oct 30, 2024
Sep 30, 2024 (Post market)
0.47 Surprise
  • Reported EPS: $5.58
  • Estimate: $5.11
  • Whisper: —
  • Surprise %: 9.2%
Aug 06, 2024
Jun 30, 2024 (Post market)
-0.04 Surprise
  • Reported EPS: $4.97
  • Estimate: $5.01
  • Whisper: —
  • Surprise %: -0.8%
May 02, 2024
Mar 31, 2024 (Post market)
0.09 Surprise
  • Reported EPS: $3.96
  • Estimate: $3.87
  • Whisper: —
  • Surprise %: 2.3%
Feb 06, 2024
Dec 31, 2023 (Post market)
0.1 Surprise
  • Reported EPS: $4.71
  • Estimate: $4.61
  • Whisper: —
  • Surprise %: 2.2%
Oct 31, 2023
Sep 30, 2023 (Pre market)
0.29 Surprise
  • Reported EPS: $4.96
  • Estimate: $4.67
  • Whisper: —
  • Surprise %: 6.2%
Aug 03, 2023
Jun 30, 2023 (Post market)
0.51 Surprise
  • Reported EPS: $5.00
  • Estimate: $4.49
  • Whisper: —
  • Surprise %: 11.4%
Apr 27, 2023
Mar 31, 2023 (Post market)
0.13 Surprise
  • Reported EPS: $3.98
  • Estimate: $3.85
  • Whisper: —
  • Surprise %: 3.4%

Financials